487 related articles for article (PubMed ID: 17855605)
1. PDZ protein interactions underlying NMDA receptor-mediated excitotoxicity and neuroprotection by PSD-95 inhibitors.
Cui H; Hayashi A; Sun HS; Belmares MP; Cobey C; Phan T; Schweizer J; Salter MW; Wang YT; Tasker RA; Garman D; Rabinowitz J; Lu PS; Tymianski M
J Neurosci; 2007 Sep; 27(37):9901-15. PubMed ID: 17855605
[TBL] [Abstract][Full Text] [Related]
2. Interaction of postsynaptic density protein-95 with NMDA receptors influences excitotoxicity in the yeast artificial chromosome mouse model of Huntington's disease.
Fan J; Cowan CM; Zhang LY; Hayden MR; Raymond LA
J Neurosci; 2009 Sep; 29(35):10928-38. PubMed ID: 19726651
[TBL] [Abstract][Full Text] [Related]
3. N-methyl-D-aspartate receptor subunit- and neuronal-type dependence of excitotoxic signaling through post-synaptic density 95.
Fan J; Vasuta OC; Zhang LY; Wang L; George A; Raymond LA
J Neurochem; 2010 Nov; 115(4):1045-56. PubMed ID: 20831617
[TBL] [Abstract][Full Text] [Related]
4. Inhibiting pro-death NMDA receptor signaling dependent on the NR2 PDZ ligand may not affect synaptic function or synaptic NMDA receptor signaling to gene expression.
Martel MA; Soriano FX; Baxter P; Rickman C; Duncan R; Wyllie DJ; Hardingham GE
Channels (Austin); 2009; 3(1):12-5. PubMed ID: 19221512
[TBL] [Abstract][Full Text] [Related]
5. Differential interaction of the tSXV motifs of the NR1 and NR2A NMDA receptor subunits with PSD-95 and SAP97.
Bassand P; Bernard A; Rafiki A; Gayet D; Khrestchatisky M
Eur J Neurosci; 1999 Jun; 11(6):2031-43. PubMed ID: 10336672
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the NMDA receptor complex and trafficking by activity-dependent phosphorylation of the NR2B subunit PDZ ligand.
Chung HJ; Huang YH; Lau LF; Huganir RL
J Neurosci; 2004 Nov; 24(45):10248-59. PubMed ID: 15537897
[TBL] [Abstract][Full Text] [Related]
7. Specific targeting of pro-death NMDA receptor signals with differing reliance on the NR2B PDZ ligand.
Soriano FX; Martel MA; Papadia S; Vaslin A; Baxter P; Rickman C; Forder J; Tymianski M; Duncan R; Aarts M; Clarke P; Wyllie DJ; Hardingham GE
J Neurosci; 2008 Oct; 28(42):10696-710. PubMed ID: 18923045
[TBL] [Abstract][Full Text] [Related]
8. Differential interaction of NMDA receptor subtypes with the post-synaptic density-95 family of membrane associated guanylate kinase proteins.
Cousins SL; Papadakis M; Rutter AR; Stephenson FA
J Neurochem; 2008 Feb; 104(4):903-13. PubMed ID: 18233995
[TBL] [Abstract][Full Text] [Related]
9. Differential modulation of NR1-NR2A and NR1-NR2B subtypes of NMDA receptor by PDZ domain-containing proteins.
Iwamoto T; Yamada Y; Hori K; Watanabe Y; Sobue K; Inui M
J Neurochem; 2004 Apr; 89(1):100-8. PubMed ID: 15030393
[TBL] [Abstract][Full Text] [Related]
10. PSD-95 assembles a ternary complex with the N-methyl-D-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain.
Christopherson KS; Hillier BJ; Lim WA; Bredt DS
J Biol Chem; 1999 Sep; 274(39):27467-73. PubMed ID: 10488080
[TBL] [Abstract][Full Text] [Related]
11. P38 MAPK is involved in enhanced NMDA receptor-dependent excitotoxicity in YAC transgenic mouse model of Huntington disease.
Fan J; Gladding CM; Wang L; Zhang LY; Kaufman AM; Milnerwood AJ; Raymond LA
Neurobiol Dis; 2012 Mar; 45(3):999-1009. PubMed ID: 22198502
[TBL] [Abstract][Full Text] [Related]
12. Interactions of postsynaptic density-95 and the NMDA receptor 2 subunit control calpain-mediated cleavage of the NMDA receptor.
Dong YN; Waxman EA; Lynch DR
J Neurosci; 2004 Dec; 24(49):11035-45. PubMed ID: 15590920
[TBL] [Abstract][Full Text] [Related]
13. Inhalational anesthetics disrupt postsynaptic density protein-95, Drosophila disc large tumor suppressor, and zonula occludens-1 domain protein interactions critical to action of several excitatory receptor channels related to anesthesia.
Tao F; Chen Q; Sato Y; Skinner J; Tang P; Johns RA
Anesthesiology; 2015 Apr; 122(4):776-86. PubMed ID: 25654436
[TBL] [Abstract][Full Text] [Related]
14. Excitotoxicity and focal cerebral ischemia induce truncation of the NR2A and NR2B subunits of the NMDA receptor and cleavage of the scaffolding protein PSD-95.
Gascón S; Sobrado M; Roda JM; Rodríguez-Peña A; Díaz-Guerra M
Mol Psychiatry; 2008 Jan; 13(1):99-114. PubMed ID: 17486105
[TBL] [Abstract][Full Text] [Related]
15. A novel family of adhesion-like molecules that interacts with the NMDA receptor.
Wang CY; Chang K; Petralia RS; Wang YX; Seabold GK; Wenthold RJ
J Neurosci; 2006 Feb; 26(8):2174-83. PubMed ID: 16495444
[TBL] [Abstract][Full Text] [Related]
16. Tat-NR2B9c prevents excitotoxic neuronal superoxide production.
Chen Y; Brennan-Minnella AM; Sheth S; El-Benna J; Swanson RA
J Cereb Blood Flow Metab; 2015 May; 35(5):739-42. PubMed ID: 25669908
[TBL] [Abstract][Full Text] [Related]
17. Trafficking of the NMDAR2B receptor subunit distal cytoplasmic tail from endoplasmic reticulum to the synapse.
Standley S; Petralia RS; Gravell M; Hamilton R; Wang YX; Schubert M; Wenthold RJ
PLoS One; 2012; 7(6):e39585. PubMed ID: 22761831
[TBL] [Abstract][Full Text] [Related]
18. Flavonoids from Radix Scutellariae as potential stroke therapeutic agents by targeting the second postsynaptic density 95 (PSD-95)/disc large/zonula occludens-1 (PDZ) domain of PSD-95.
Tang W; Sun X; Fang JS; Zhang M; Sucher NJ
Phytomedicine; 2004; 11(4):277-84. PubMed ID: 15185839
[TBL] [Abstract][Full Text] [Related]
19. Intrathecal injection of the peptide myr-NR2B9c attenuates bone cancer pain via perturbing N-methyl-D-aspartate receptor-PSD-95 protein interactions in mice.
Liu Y; Cui X; Sun YE; Yang X; Ni K; Zhou Y; Ma Z; Gu X
Anesth Analg; 2014 Jun; 118(6):1345-54. PubMed ID: 24842180
[TBL] [Abstract][Full Text] [Related]
20. NMDA receptor desensitization regulated by direct binding to PDZ1-2 domains of PSD-95.
Sornarajah L; Vasuta OC; Zhang L; Sutton C; Li B; El-Husseini A; Raymond LA
J Neurophysiol; 2008 Jun; 99(6):3052-62. PubMed ID: 18400955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
